Steris (STE) Research & Development (2018 - 2026)

Steris' Research & Development history runs 9 years deep, the most recent figure standing at $28.8 million for Q1 2026.

• In Q1 2026, Research & Development rose 4.35% year-over-year to $28.8 million; the TTM figure through Mar 2026 stood at $112.9 million (up 4.93% YoY), while the FY2026 annual figure was $112.9 million, up 4.93% from the prior year.
• Research & Development was $28.8 million for Q1 2026 at Steris, down from $29.5 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $29.5 million in Q4 2025 to a low of $23.3 million in Q1 2023.
• Historically, Research & Development has averaged $26.3 million across 5 years, with a median of $26.3 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Research & Development surged 41.69% in 2022, then dropped 6.17% in 2023.
• A 5-year view of Research & Development shows it stood at $25.5 million in 2022, then fell by 1.02% to $25.3 million in 2023, then advanced by 8.49% to $27.4 million in 2024, then grew by 7.66% to $29.5 million in 2025, then declined by 2.37% to $28.8 million in 2026.
• The last three Research & Development figures came in at $28.8 million (Q1 2026), $29.5 million (Q4 2025), and $28.2 million (Q3 2025), per Business Quant data.